Base Year
Historical Year
Forecast Year
The United States medical cannabis industry attained a value of around USD 15.10 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 12.2% to reach a value of about USD 42.56 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cannabis refers to a psychoactive medication extracted from the Cannabaceae family cannabis plant. The drug was used in ancient Indian, Chinese, Egyptian as well as Islamic cultures. These days, cannabis is used in treating a wide range of diseases, such as cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multi-sclerosis, AIDS, amyotrophic side sclerosis (ALS), Alzheimer's, post-traumatic stress disorder (PTSD), Parkinson's, and Tourette's. Cannabis has also been approved for medicinal use in multiple countries with varying levels of legal constraints due to its therapeutic benefits.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product, the industry can be divided into:
Based on species, the industry is segmented into:
The market can be broadly categorised based on its applications into:
The distribution channels can be divided into:
The EMR report looks into the regional markets like New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The ageing population in the region has played a vital role in raising the market for medical cannabis, as geriatric patients are more prone to developing chronic diseases and need more doctor visits. Clinical trials, R&D, and the commercialisation of indications based on cannabis are also anticipated to catalyse the market growth.
Although spending on health products is less likely to fluctuate, medical marijuana use is subject to unusual shifts in disposable incomes. As a result, higher disposable incomes will have a positive effect on medical cannabis demand. The application sector is being led by the chronic pain segment.
The report presents a detailed analysis of the following key players in the United States medical cannabis industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Species |
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the United States medical cannabis market attained a value of nearly USD 15.10 billion.
The market is projected to grow at a CAGR of 12.2% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 42.56 billion by 2032.
The major drivers of the industry, such as the rising ageing population and clinical trials, increasing disposable income, and the increasing commercialisation of the product, are expected to aid the market growth.
The key market trend guiding the growth of the market includes the rising research and development activities in the industry.
The major regions in the industry are New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
The dominant products of medical cannabis in the industry are buds, oils, and tinctures.
The leading species of the product in the market are indica, sativa, and hybrid.
The major applications of medical cannabis in the industry are chronic pain, mental disorders, and cancer, among others.
The significant distribution channels of the product are dispensaries, pharmacies, and online retailers.
The major players in the industry are Green Man Cannabis, Los Sueños Farms LLC, Copperstate Farms, LLC, Harvest Health & Recreation, Inc., and GrowHealthy Holdings, LLC, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share